The UK Government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.

 

Wockhardt, the global pharmaceutical and biotechnology major, hosted a visit at its Wrexham facility in North Wales of the Prime Minister of the United Kingdom, Boris Johnson. The Prime Minister inspected the Wockhardt’s fill finish production line and was accompanied by local Wrexham conservative MP Sarah Atherton.

 

Prime Minister Boris Johnson said, “Today marks the next stage in the UK distribution of the coronavirus vaccine. Our agreement with Wockhardt is a significant milestone for the British life science industry and will help produce the vaccines this country needs.”

 

“I am grateful to have met with some of the hardworking team here in Wales, who are helping take us one step closer to defeating this virus,” added Johnson. 

 

While acknowledging the visit as a mark of Honour, the Founder Chairman of Wockhardt Dr. Habil Khorakiwala said, “With four decades of expertise and experience behind us, we are able to quickly rise to the occasion, scale up the manufacture of much desired vaccines and assist in mitigating the global impact of COVID-19. We have more than a billion dosage capacity for both API & fill and finish globally and can be a partner to fight the world's most demanding need of the hour in COVID-19.”

 

Speaking about the visit Ravi Limaye, Managing Director Wockhardt UK said, “We are privileged to host the Prime Minister and showcase our world class manufacturing capability here in Wrexham. Our sophisticated sterile facility and highly skilled workforce are a prime example of why the manufacturing sector is a major employer accounting for around 9% of the UK workforce.”